BioSpace News Archive

Genetown

SpyBiotech Adds Epstein-Barr Virus Research and Development Collaboration with The University of Oxford

SpyBiotech, a biotechnology company with novel vaccine platform technologies that can target infectious diseases, cancer, and chronic diseases, announced a sponsored research agreement with The University of Oxford for the development of a vaccine against Epstein-Barr virus.

May 23, 2024
·
4 min read
Genetown

Haemonetics Prices Upsized Private Placement of $600 Million Convertible Senior Notes

Haemonetics Corporation announced the pricing of its offering of $600,000,000 aggregate principal amount of 2.50% Convertible Senior Notes due 2029 in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.

May 23, 2024
·
11 min read
Business

111, Inc. Announces First Quarter 2024 Unaudited Financial Results

111, Inc. today announced its unaudited financial results for the first quarter ended March 31, 2024.

May 23, 2024
·
21 min read
Amphista Therapeutics unveils new differentiated mechanism of action for BRD9 degradation at 2024 Protein Degradation in Focus Symposium

Amphista Therapeutics unveils new differentiated mechanism of action for BRD9 degradation at 2024 Protein Degradation in Focus Symposium First presentation of a novel mechanism of action for the degradation of BRD9 – completely differentiated from cereblon- or VHL-based PROTACs.

May 23, 2024
·
4 min read
Business

Medtronic reports full year and fourth quarter fiscal 2024 financial results; announces dividend increase

Medtronic plc announced financial results for its fourth quarter and fiscal year 2024, which ended April 26, 2024.

May 23, 2024
·
33 min read
BioMidwest

OneMedNet Reports Greater than Five-Fold Expansion of iRWD™ Network and Platform

OneMedNet Corporation, the leading curator of regulatory-grade Real World Data, inclusive of electronic health records, laboratory results and medical imaging, is pleased to announce a greater than five -fold expansion of its proprietary iRWD™ network and platform.

May 23, 2024
·
4 min read
Business

atai Life Sciences Strengthens Board with Appointment of Two New Independent Directors

atai Life Sciences today announced the appointment of Scott Braunstein, M.D., and Laurent Fischer, M.D., as independent directors of atai’s supervisory board (“Board”) subject to applicable legal requirements.

May 23, 2024
·
3 min read
BioMidwest

BIO-TECHNE TO PRESENT AT THE 2024 LEERINK PARTNERS HEALTHCARE CROSSROADS CONFERENCE

Bio-Techne Corporation today announced that Kim Kelderman, President and Chief Executive Officer will present at the 2024 Leerink Partners Healthcare Crossroads Conference on Wednesday, May 29, 2024 , at 8:40 a.m. CDT.

May 23, 2024
·
1 min read
Biotech Beach

New data from the Phase 3 NEURO-TTRansform study evaluating WAINUA™ (eplontersen) to be presented at the 2024 International Symposium on Amyloidosis (ISA)

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that it will present new subgroup analyses from Ionis and AstraZeneca’s Phase 3 NEURO-TTRansform study of WAINUA™ (eplontersen) at the 2024 International Symposium on Amyloidosis (ISA) in Rochester, Minnesota, May 26-30.

May 23, 2024
·
6 min read
Pharm Country

Bristol Myers Squibb to Present Data at the 2024 American Society of Clinical Psychopharmacology Annual Meeting

Bristol Myers Squibb (NYSE: BMY) today announced the presentation of data at the 2024 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting, taking place May 28-31, 2024 in Miami, FL.

May 23, 2024
·
7 min read